Trials / Unknown
UnknownNCT01464411
Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan
Phase II Clinical Trial of Dasatinib First Line Therapy for Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Kanto CML Study Group · Academic / Other
- Sex
- All
- Age
- 20 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate effectiveness of Dasatinib as the first line therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase in Japan.
Conditions
Timeline
- Start date
- 2011-07-01
- First posted
- 2011-11-03
- Last updated
- 2011-11-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01464411. Inclusion in this directory is not an endorsement.